semaglutide and cardiovascular outcomes in obesity without diabetes journal club patients with and prevalent heart failure: a prespecified analysis of the SELECT trial Semaglutide journal club | PPTX

The other forms will be called out by name or acronym when theyre used

doi: 10.2174/1874285801812010230 39 DaoudZ.SuraM.Abdel-MassihR

Frank Lee, answers your questions about semaglutide and tirzepatide

Ozempic slows gastric emptying, which could potentially delay the absorption of oral anticoagulants, particularly warfarin

J Clin Invest 55(6):12029 Modi A, Agrawal A, Morgan F (2017) Euglycemic diabetic ketoacidosis: a review

Provides Cardiovascular Benefits (Anti-inflammatory) Clinical trials (e.g., SUSTAIN-6, SELECT) have shown semaglutide reduces the risk of major adverse cardiovascular events (heart attack, stroke, CV death) in people with type 2 diabetes and high cardiovascular risk